Evidence map›Paper›PMID 37823910›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2024

Simultaneous high-resolution whole-brain MR spectroscopy and [

Hui Huang, Miao Zhang, Yibo Zhao, Yudu Li, Wen Jin, Rong Guo, Wei Liu, Bingyang Cai, Jiwei Li, Siyu Yuan and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 3 countries.

Hui Huang *School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.
Miao Zhang *Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Yibo ZhaoBeckman Institute for Advanced Sciences and Technology, University of Illinois at Urbana Champaign, Urbana, IL, 61801, USA.
Yudu LiBeckman Institute for Advanced Sciences and Technology, University of Illinois at Urbana Champaign, Urbana, IL, 61801, USA.
Wen JinBeckman Institute for Advanced Sciences and Technology, University of Illinois at Urbana Champaign, Urbana, IL, 61801, USA.
Rong GuoBeckman Institute for Advanced Sciences and Technology, University of Illinois at Urbana Champaign, Urbana, IL, 61801, USA.
Wei LiuDepartment of Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Bingyang CaiSchool of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.
Jiwei LiSchool of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.
Siyu YuanSchool of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.
Xinyun HuangDepartment of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Xiaozhu LinDepartment of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Zhi-Pei LiangBeckman Institute for Advanced Sciences and Technology, University of Illinois at Urbana Champaign, Urbana, IL, 61801, USA.
Biao LiDepartment of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. lb10363@rjh.com.cn.
Jie LuoSchool of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China. jieluo@sjtu.edu.cn.ORCID 0000-0002-0543-4778
Shanghai Jiao Tong University · CNUniversity of Illinois Urbana-Champaign · US

Funding

National Natural Science Foundation of China No. 62101321National Natural Science Foundation of China No. 82372073Shanghai Municipal Health Commission No. 202240031Shanghai Municipal Key Clinical Specialty shslczdzk03403
6 · The paper itself

Abstract

purposePrecise lateralizing the epileptogenic zone in patients with drug-resistant mesial temporal lobe epilepsy (mTLE) remains challenging, particularly when routine MRI scans are inconclusive (MRI-negative). This study aimed to investigate the synergy of fast, high-resolution, whole-brain MRSI in conjunction with simultaneous [

methodsForty-eight drug-resistant mTLE patients (M/F 31/17, age 12-58) underwent MRSI and [

resultsThe high-resolution whole-brain MRSI data offers metabolite maps at comparable resolution to [

conclusionThis paper reports the first metabolic imaging study using simultaneous high-resolution MRSI and [

Indexed as

Epilepsy, Temporal LobeAdolescentAdultBrainChildFluorodeoxyglucose F18HippocampusHumansMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMiddle AgedPositron-Emission TomographyTomography, X-Ray ComputedYoung AdultFluorodeoxyglucose F18GlucoseLateralizationN-Acetyl aspartatePET/MRSITemporal lobe epilepsy

Identifiers

PMID37823910
OpenAlexW4387564400

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.